Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Net Cash Flow (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Net Cash Flow for 3 consecutive years, with -$21.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Net Cash Flow fell 204.47% year-over-year to -$21.5 million, compared with a TTM value of -$6.1 million through Sep 2025, down 111.04%, and an annual FY2024 reading of $33.4 million, down 42.92% over the prior year.
  • Net Cash Flow was -$21.5 million for Q3 2025 at SBC Medical Group Holdings, down from $15.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $99.8 million in Q2 2023 and bottomed at -$21.5 million in Q3 2025.
  • Average Net Cash Flow over 3 years is $16.9 million, with a median of $13.1 million recorded in 2024.
  • The sharpest move saw Net Cash Flow skyrocketed 192.4% in 2024, then plummeted 204.47% in 2025.
  • Year by year, Net Cash Flow stood at $20.9 million in 2023, then tumbled by 102.25% to -$470307.0 in 2024, then tumbled by 4466.05% to -$21.5 million in 2025.
  • Business Quant data shows Net Cash Flow for SBC at -$21.5 million in Q3 2025, $15.2 million in Q2 2025, and $669434.0 in Q1 2025.